Company Overview - Shuiyang Co., Ltd. is located in Changsha, Hunan Province, and was established on November 1, 2012. The company went public on February 8, 2018. Its main business involves the research, production, and sales of cosmetics [1][2] - The revenue composition of the main business includes: 81.84% from lotions and creams, 17.32% from masks, and 0.84% from other products [1] Financial Performance - For the first half of 2025, Shuiyang Co., Ltd. achieved operating revenue of 2.5 billion yuan, representing a year-on-year growth of 9.02%. The net profit attributable to shareholders was 123 million yuan, with a year-on-year increase of 16.54% [2] - Since its A-share listing, the company has distributed a total of 142 million yuan in dividends, with 77.81 million yuan distributed over the past three years [3] Stock Performance - As of September 22, the stock price of Shuiyang Co., Ltd. increased by 2.00%, reaching 21.93 yuan per share, with a total market capitalization of 8.553 billion yuan [1] - The stock has risen by 65.89% year-to-date, with a slight decline of 0.86% over the last five trading days, and a 30.93% increase over the past 60 days [1] Shareholder Information - As of September 10, the number of shareholders for Shuiyang Co., Ltd. was 27,000, with an average of 13,296 circulating shares per person [2] - Notable institutional shareholders include BlackRock China New Horizons Mixed A and Hong Kong Central Clearing Limited, both of which are new entrants among the top ten circulating shareholders [3] Market Activity - The company has seen a net inflow of main funds amounting to 6.1559 million yuan, with significant buying activity from large orders [1] - Shuiyang Co., Ltd. has appeared on the trading leaderboard once this year, with a net purchase of 24.4889 million yuan on May 28 [1] Industry Context - Shuiyang Co., Ltd. operates within the beauty and personal care sector, specifically in the branded cosmetics segment. It is associated with concepts such as margin financing, share buybacks, and e-commerce [2]

Investment Rating - The investment rating for the company is "Buy" (maintained) [5] Core Views - The company reported a revenue of 2.5 billion yuan for the first half of 2025, representing a year-on-year growth of 9.02%. The net profit attributable to the parent company was 123 million yuan, up 16.54% year-on-year [5] - The company continues to focus on high-end self-owned brands, with significant growth in its product lines, particularly in skincare [11] - The gross margin improved to 64.61%, an increase of 3.13 percentage points, while the net margin slightly increased to 4.94%, up 0.17 percentage points [11] Financial Performance - For the first half of 2025, the company achieved a revenue of 2.5 billion yuan, with a net profit of 123 million yuan, and a non-recurring net profit of 121 million yuan [5] - The second quarter of 2025 saw a revenue of 1.414 billion yuan, a year-on-year increase of 12.16%, and a net profit of 81 million yuan, up 23.76% year-on-year [5] - The company expects revenues of 4.69 billion yuan, 5.22 billion yuan, and 5.85 billion yuan for 2025, 2026, and 2027 respectively, with growth rates of 10.67%, 11.32%, and 12.06% [11] Brand and Product Development - The company’s self-owned brands generated 1.039 billion yuan in revenue, accounting for 41.55% of total revenue, with a gross margin of 76.83% [11] - The product categories of water emulsion cream and masks achieved revenues of 1.997 billion yuan and 423 million yuan, respectively, with year-on-year growth rates of 11.70% and 17.96% [11] - The company plans to open 50 SPA stores nationwide by 2027 to enhance its offline presence [11] Valuation and Investment Recommendations - The current market capitalization corresponds to a price-to-earnings ratio (P/E) of 31.3, 26.5, and 22.8 for the years 2025, 2026, and 2027 respectively [11] - The company is expected to see a significant increase in net profit, with projections of 275 million yuan, 325 million yuan, and 377 million yuan for 2025, 2026, and 2027, reflecting growth rates of 149.9%, 18.3%, and 16.0% [11]

Company Overview - Water Goat Co., Ltd. is located in Changsha, Hunan Province, and was established on November 1, 2012. The company was listed on February 8, 2018. Its main business involves the research, production, and sales of cosmetics [1][2] - The main revenue composition includes: 81.84% from lotions and creams, 17.32% from masks, and 0.84% from other products [1] Financial Performance - For the first half of 2025, Water Goat achieved operating revenue of 2.5 billion yuan, representing a year-on-year growth of 9.02%. The net profit attributable to the parent company was 123 million yuan, with a year-on-year increase of 16.54% [2] - Since its A-share listing, the company has distributed a total of 142 million yuan in dividends, with 77.81 million yuan distributed over the past three years [3] Stock Market Activity - As of September 2, Water Goat's stock price increased by 2.00%, reaching 22.93 yuan per share, with a trading volume of 521 million yuan and a turnover rate of 6.44%. The total market capitalization is 8.943 billion yuan [1] - Year-to-date, the stock price has risen by 73.45%, with a recent decline of 3.66% over the past five trading days, and increases of 33.24% over the past 20 days and 20.30% over the past 60 days [1] - The company has appeared on the "Dragon and Tiger List" once this year, with the most recent appearance on May 28, where it recorded a net purchase of 24.49 million yuan [1] Shareholder Information - As of August 8, the number of shareholders for Water Goat was 27,000, an increase of 5.01% from the previous period. The average circulating shares per person decreased by 4.77% to 13,296 shares [2] - Notable institutional holdings include BlackRock China New Horizons Mixed A as the seventh largest shareholder with 2.6 million shares, and Hong Kong Central Clearing Limited as the eighth largest shareholder with 2.524 million shares, both being new shareholders [3]

Investment Rating - The report upgrades the investment rating of the company to "Buy" [1] Core Views - The company has shown a quarter-on-quarter improvement in revenue growth and net profit in Q2 2025, indicating effective business structure optimization [5][9] - The company's self-owned brand revenue has increased to 41.6% of total revenue, with significant growth in key product categories such as lotions and masks [6] - The high-end beauty group strategy is progressing well, with expectations for continued revenue and profit growth from key brands [9] Financial Performance - In H1 2025, the company achieved a revenue of 2.5 billion yuan, a year-on-year increase of 9%, and a net profit attributable to shareholders of 120 million yuan, up 16.5% [5] - The gross margin improved by 3.1 percentage points to 64.6% in H1 2025, with self-owned brands achieving a gross margin of 76.8% [7] - Operating cash flow turned positive with a net inflow of 170 million yuan, reflecting improved operational efficiency [8] Business Segmentation - Self-owned brands generated 1.04 billion yuan in revenue, while agency brands accounted for 1.46 billion yuan [6] - Online sales contributed 90% of total revenue, with significant growth in third-party platforms like Taobao and Douyin [6] Future Projections - The company expects to achieve net profits of 290 million yuan, 350 million yuan, and 430 million yuan for the years 2025, 2026, and 2027 respectively, with corresponding EPS of 0.74, 0.90, and 1.10 yuan [10] - The report anticipates a revenue growth rate of 17.5% in 2025, followed by 16.4% and 16.8% in the subsequent years [10]

Core Insights - The company reported a revenue of 2.5 billion yuan for the first half of 2025, representing a year-on-year increase of 9%, and a net profit attributable to shareholders of 120 million yuan, up 16.5% year-on-year [1] - The growth rate accelerated in the second quarter, with revenue and net profit increasing by 12.2% and 23.8% respectively compared to the first quarter [1] Revenue Breakdown - Own brand revenue accounted for 41.6% of total revenue, with significant growth in key categories such as lotions and masks, achieving double-digit revenue growth [2] - Total revenue from own brands reached 1.04 billion yuan in the first half of 2025, while agency brand revenue was 1.46 billion yuan [2] - Online and offline channel revenues were 90% and 10% respectively, with online revenue growing by 9.7% and offline by 3% year-on-year [2] Product Performance - Revenue from lotions and masks constituted 80% and 17% of total revenue, with respective year-on-year growth of 11.7% and 18% [3] - Gross margin improved by 3.1 percentage points to 64.6%, with own brand gross margin at 76.8%, up 5.7 percentage points [3] Financial Metrics - The company experienced an increase in expense ratio by 3.2 percentage points to 57.5%, driven by higher sales and management expenses [3][4] - Inventory decreased by 8.9% year-on-year to 810 million yuan, with inventory turnover days at 166 days, down 5 days [4] - Accounts receivable decreased by 13.2% year-on-year to 400 million yuan, with turnover days at 27 days, down 7 days [4] Strategic Outlook - The high-end beauty group strategy is progressing well, with expectations for performance improvements as brand presence expands [5] - The company anticipates continued growth in own brand business, with upward revisions to net profit forecasts for 2025-2027 [5] - The company plans to enhance brand positioning and customer engagement through the opening of new stores and innovative customer experiences [5]

Core Viewpoint - The report highlights the financial performance and strategic initiatives of Shuiyang Group Co., Ltd. for the first half of 2025, showcasing a growth in revenue and net profit while emphasizing the company's focus on high-end brand development and digital transformation. Financial Performance - The company achieved a revenue of CNY 2,499.73 million, representing a year-on-year increase of 9.02% compared to CNY 2,292.85 million in the same period last year [5] - The net profit attributable to shareholders was CNY 120.59 million, up 16.54% from CNY 103.45 million in the previous year [5] - The basic earnings per share increased by 17.41% to CNY 0.3190 from CNY 0.2717 [5] - The total assets at the end of the reporting period were CNY 4,207.72 million, a slight decrease of 1.02% from CNY 4,251.11 million at the end of the previous year [5] Business Overview - Shuiyang Group primarily engages in the research, production, and sales of cosmetics, covering a wide range of products including masks, lotions, creams, and makeup [6] - The company has established deep partnerships with major e-commerce platforms such as Tmall, Taobao, Douyin, JD.com, and others, ensuring comprehensive online and offline sales channels [6][8] - The company has a global sales network with brand outlets or flagship stores in major cities across China, the UK, France, the US, and Canada [6] Industry Development - The retail sales of consumer goods in China reached CNY 24,545.8 billion, growing by 5.0% year-on-year, with cosmetics retail sales amounting to CNY 229.1 billion, a growth of 2.9% [8] - The demand for beauty products is increasingly diversified, with the Z generation becoming a significant consumer group, emphasizing product efficacy and aesthetic appeal [9] - The industry is witnessing a transformation in sales channels, with traditional e-commerce adjusting to enhance quality and service experiences, while offline channels are shifting towards experiential and service-oriented models [9] Strategic Initiatives - The company is committed to enhancing brand assets and product quality, focusing on building a marketing system that integrates online and offline channels [10] - Shuiyang Group aims to establish itself as a "global emerging luxury beauty group," emphasizing sustainable development and a multi-brand matrix [10] - The company has implemented a digital system that covers various operational aspects, enhancing efficiency in market analysis, product development, and supply chain management [15][16] R&D and Innovation - The company has a robust R&D framework, focusing on skin mechanism exploration and innovative raw material development, with 18 patents applied for and 4 granted during the reporting period [11] - Research on Eastern skin mechanisms and the development of new raw materials based on Chinese plants have been prioritized, showcasing the company's commitment to innovation [12][13] - The company has introduced new product formulations and technologies aimed at improving consumer experience and product efficacy [14][15]

Group 1 - The company has been deeply engaged in the plant-based skincare market for 30 years, focusing on the "Plant Doctor" brand, and is one of the largest single-brand beauty store chains in China [4][10] - The company achieved revenue of 2.12 billion, 2.15 billion, and 2.16 billion yuan from 2022 to 2024, with a compound annual growth rate (CAGR) of 24% for net profit, indicating strong profitability [4][21] - The company has a well-established sales model that includes a mix of distribution and direct sales, with a comprehensive online and offline presence [4][25] Group 2 - The cosmetics market is steadily growing, transitioning from quantity to quality, with domestic brands, online sales, and niche segments driving growth [4][32] - The skincare segment remains dominant, accounting for 50.5% of the overall cosmetics market in China, with a market size of 271.2 billion yuan in 2024 [36][39] - E-commerce has rapidly risen, with its share of cosmetics sales increasing from 22% in 2016 to 47% in 2024, showcasing the efficiency and flexibility of online platforms [42][43] Group 3 - The company has a strong brand presence, ranking 13th in market share, and has received recognition as a leading plant-based skincare brand [47][50] - The company operates over 4,300 offline stores, providing extensive market coverage, while also achieving significant growth in online sales through platforms like Douyin and Taobao [51][55] - The company has established partnerships with research institutions to develop innovative plant-based ingredients, enhancing its product offerings [60]

Core Viewpoint - Beijing Plant Doctor Cosmetics Co., Ltd. is preparing for an IPO, with plans to issue up to 26.67 million shares, accounting for at least 25% of the total share capital post-issue [2] Financial Performance - The company projects revenue of 2.116 billion yuan, 2.150 billion yuan, and 2.155 billion yuan for the years 2022, 2023, and 2024 respectively, with net profits of 168 million yuan, 229 million yuan, and 242 million yuan for the same years [2] - The gross profit margins for the years 2022, 2023, and 2024 are expected to be 55.22%, 60.34%, and 58.90% respectively [2] Product Segmentation - The main revenue driver is the water and lotion cream segment, projected to generate 1.218 billion yuan in 2024, accounting for 56.52% of total revenue [3] - The essence and essence oil segment is expected to contribute 465 million yuan, representing 21.59% of total revenue, while face masks account for 16.28% [4] Sales Channels - The company employs a mixed sales model, primarily through distribution (66.72%) and supplemented by direct sales (33.28%) [8] - As of the end of 2024, the company operates 4,328 offline chain stores, with 3,830 authorized specialty stores and 498 direct stores [4] Market Position - Plant Doctor holds a 0.8% market share in the Chinese cosmetics market, ranking 9th among domestic brands [8] - The company’s revenue from the distribution model in 2024 is projected to be 1.366 billion yuan, accounting for 63.37% of total revenue [8] R&D and Competitive Edge - The company maintains a stable R&D expense ratio of 3% to 3.5% over the past three years, which is higher than several listed competitors [9] - Collaboration with the Kunming Institute of Botany has led to the development of a star product featuring Dendrobium orchid [9] Challenges - The company faces inventory pressure, with stock increasing from 192 million yuan at the end of 2023 to 223 million yuan at the end of 2024 [9] - Regulatory penalties on some stores due to violations have raised concerns about potential impacts on sales and performance [9]

Core Viewpoint - The high-end transformation of Shuiyang Group is facing challenges, as evidenced by a significant decline in revenue and profit in the 2024 annual report, raising questions about whether this strategy is beneficial or detrimental to the company [1]. Financial Performance - Shuiyang Group reported a revenue of 4.237 billion yuan in 2024, a year-on-year decrease of 5.69% [1]. - The net profit attributable to shareholders fell by 62.63% to 110 million yuan, while the non-recurring net profit decreased by 56.74% to 118 million yuan [1]. - Sales expenses increased by 11.89% to 2.079 billion yuan, accounting for 49.07% of total revenue [6]. Business Strategy - The company is transitioning to become a "global new luxury beauty group," which involves restructuring its business and increasing investment in high-end brands [1][2]. - Shuiyang Group has made significant acquisitions, including the purchase of the French luxury skincare brand EDB for over 300 million yuan and the acquisition of the American luxury skincare brand RéVive [2][3]. Product Performance - Revenue from self-owned brands reached 1.651 billion yuan, representing approximately 38.97% of total revenue, with a gross margin of 74.27% [3]. - All product categories, including creams, masks, and brand management services, experienced revenue declines, with creams generating 3.351 billion yuan (down 4.38%) and masks generating 734 million yuan (down 10.8%) [4][5]. Research and Development - R&D expenses increased by only 7.32% to 82.1755 million yuan, indicating a lower investment compared to sales expenses [7]. - The company has established a stock incentive plan, but it failed to meet performance targets, resulting in the cancellation of unvested shares for 258 individuals [7][8].